Octavus Consulting- Evidence-Based Consulting Services.

Call us: +91 87500 88882

Email us: bd@octavusconsulting.com

Contact Us
Contact Us

Babli Singh

  • Home
  • Author: Babli Singh
15
Jan
No Comments

Q2W Newsletter: Jan’26 Part 1

Key Outcomes: Daiichi initiated P3 of Datopotamab deruxtecan (Datroway) for NSCLC, Pfizer’s P3 BREAKWATER study showed promising combinations in BRAF V600E mCRC, reinforcing global ADC and targeted therapy focus Biopharma deal-making remained strong across oncology and immunology, with multiple high-value licensing and collaboration agreements Pipeline momentum was robust in neurology and rare diseases, as Eisai/Biogen […]
Continue Reading
15
Dec
No Comments

Animal Health 2025 | Market Trends & Innovations Explained – Octavus Insights Corner

Insights Details Month: Oct 25 Tags: Animal Health, Conference, Pre-clinical, Phase 1, Phase 2, Phase 3, US FDA, Europe, Company Profile, Product profile, Deal Analysis, Funding Analysis, Landscape, Livestock Animals, Companion Animals, Top Diseases, Grooming & Smart Health Monitoring Device, Economic Impact, Emerging Technology, Artificial Intelligence, Digital Technology, Policy, USA, Veterinary Clinical Trials, Global Market […]
Continue Reading
29
Oct
No Comments

Learning from Trial Failures: Turning Setbacks into Strategic Data Assets

Every company has a “Phase III heartbreak.” The molecule looked perfect-mechanism sound, safety profile strong- but the primary endpoint missed. Most teams bury the data. At Octavus Consulting, we treat it as a gold mine. The Opportunity in Failure Clinical failures hold information about trial design, recruitment, and patient heterogeneity that can redefine the next […]
Continue Reading
03
Sep
No Comments

Bridging the Biopharma Gap with Consulting Firms

Shots:  Where the biopharmaceutical industry is hedged by the Inflation Reduction Act and stringent regulatory compliance, keeping up with the unabating updates from the industry can be challenging. To keep themselves afloat in the vortex of uncertainties, biopharma companies onboard consulting firms as their saviors to understand the evolving landscapes of the healthcare system and […]
Continue Reading

Subscribe Newsletter

Sign up to receive notifications about the latest news and events from us!